Epigenomics AG Statistics

Total Valuation

Epigenomics AG has a market cap or net worth of 992,909. The enterprise value is 12.85 million.

Market Cap	992,909
Enterprise Value	12.85M

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	672,136

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.20
PB Ratio	-0.09
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.70
EV / Sales	120.53
EV / EBITDA	9.61
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 194.20

Current Ratio	194.20
Quick Ratio	185.40
Debt / Equity	n/a
Debt / EBITDA	9.65
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-5.62%
Return on Invested Capital (ROIC)	-31.61%
Return on Capital Employed (ROCE)	-9.38%
Revenue Per Employee	16,220
Profits Per Employee	-578,390
Employee Count	6
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.18% in the last 52 weeks. The beta is 1.17, so Epigenomics AG's price volatility has been higher than the market average.

Beta (5Y)	1.17
52-Week Price Change	+9.18%
50-Day Moving Average	0.68
200-Day Moving Average	1.91
Relative Strength Index (RSI)	49.73
Average Volume (20 Days)	2,068

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Epigenomics AG had revenue of 97,319 and -3.47 million in losses.

Revenue	97,319
Gross Profit	97,319
Operating Income	-1.15M
Pretax Income	-3.47M
Net Income	-3.47M
EBITDA	1.22M
EBIT	-1.15M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 959,727 in cash and 11.78 million in debt, giving a net cash position of -10.82 million.

Cash & Cash Equivalents	959,727
Total Debt	11.78M
Net Cash	-10.82M
Net Cash Per Share	n/a
Equity (Book Value)	-11.24M
Book Value Per Share	n/a
Working Capital	1.00M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.25M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,181.91%
Pretax Margin	-3,565.94%
Profit Margin	n/a
EBITDA Margin	1,254.26%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Epigenomics AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-349.51%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a